PRCT 株価推移チャート
PRCT 財務
Procept Biorobotics Corp
$21.25
-7.16%
$-1.64
終値： Aug 12, 16:00:00 GMT-4
$21.22
-0.09%
$-0.02
アフターマーケット：Aug 12, 19:18:22 GMT-4
戻る
Procept Biorobotics Corp (PRCT) 財務
主要データ
前終値
$22.89
始値
$22.45
当日レンジ
$21.17 - $22.68
52週レンジ
$16.66 - $49.89
取引高
--
平均取引高
1.6M
配当利回り
--
1株当たり利益(TTM)
-1.83
時価総額
$1.2B
PRCTとは何ですか？
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. The company is headquartered in San Jose, California and currently employs 888 full-time employees. The company went IPO on 2021-09-15. The firm is focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The firm's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
